|
Post by mnholdem on Jun 27, 2019 11:54:35 GMT -5
Biomm split into two companies many years ago. Almost all manufactured and distribution went to Novo Nordisk.
|
|
|
Post by bioexec25 on Jun 27, 2019 13:09:42 GMT -5
|
|
|
Post by goyocafe on Jun 27, 2019 13:17:31 GMT -5
I doubt everyone at Sanofi shared the same bias against Afrezza as Brandicort did. When does Bambi step down, anyway?
|
|
|
Post by bioexec25 on Jun 27, 2019 13:29:29 GMT -5
Sanofi says Brandicourt will retire from the company September 1st. Now that’s how term limits are done. 😊.
Paul Hudson, head of Novartis’ pharma division then CEO will become CEO of Sanofi. Hmmm. 🤣
|
|
|
Post by kenken on Jun 27, 2019 14:10:15 GMT -5
Novartis is the biggest devil to the Mannkind Corporation. Every giant European company, which make a lion share from American diabetic, finance the short, want mankind to cease.
|
|
|
Post by ktim on Jun 27, 2019 14:30:42 GMT -5
Novartis is the biggest devil to the Mannkind Corporation. Every giant European company, which make a lion share from American diabetic, finance the short, want mankind to cease. Shorts don't need external financing, they've been raking in profits for years on MNKD. I think you mean Novo Nordisk. Those are often confused.
|
|
|
Post by kenken on Jun 27, 2019 15:02:20 GMT -5
Nova Nordisk (120B) and Novartis (208B) are all Europe pharmaceutical giants, based in Demark and Switzerland.
|
|
|
Post by peppy on Jun 27, 2019 16:46:16 GMT -5
Sanofi says Brandicourt will retire from the company September 1st. Now that’s how term limits are done. 😊. Paul Hudson, head of Novartis’ pharma division then CEO will become CEO of Sanofi. Hmmm. 🤣 Olivier Brandicourt is a French business executive and physician, and the current chief executive officer of Sanofi. Wikipedia Born: February 1956 ( age 63 years), France
|
|
|
Post by mnholdem on Jun 28, 2019 4:21:02 GMT -5
Off topic, but Sanofi appears to be replacing Brandicourt with Paul Hudson from Novartis.
|
|
|
Post by kenken on Jun 28, 2019 7:49:34 GMT -5
Traditional, Europe pharmaceutical giants dominated the diabetic drug field worldwide, including the United States, but Japan and China few countries. Insulin supply and price were controlled. MBA Business Course 101, play monopoly game, bankrupt the competitor.
|
|
|
Post by sportsrancho on Jul 3, 2019 5:42:23 GMT -5
|
|
|
Post by goyocafe on Jul 3, 2019 9:11:09 GMT -5
I like the note just below the video, “EBC is funded in whole or in part by the Brazilian government”. i wonder if the government has any say in the content that is disseminated by EBC?
|
|